{{Rsnum
|rsid=7192724
|Chromosome=16
|Orientation=plus
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene=PLCG2
|position=81924693
|Gene_s=PLCG2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 62.8 | 31.9 | 5.3
| HCB | 68.6 | 31.4 | 0.0
| JPT | 70.8 | 26.5 | 2.7
| YRI | 47.6 | 44.9 | 7.5
| ASW | 50.9 | 43.9 | 5.3
| CHB | 68.6 | 31.4 | 0.0
| CHD | 72.5 | 24.8 | 2.8
| GIH | 55.4 | 39.6 | 5.0
| LWK | 42.2 | 50.5 | 7.3
| MEX | 75.9 | 20.7 | 3.4
| MKK | 56.4 | 38.5 | 5.1
| TSI | 53.9 | 42.2 | 3.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=24080446
  |Trait=Breast cancer (menopausal hormone therapy interaction)
  |Title=Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.
  |RiskAllele=
  |Pval=3E-6
  |OR=1.24
  |ORtxt=[1.13-1.36]
  }}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}